Table 1. Study participants.
| Participanta | Sex | Age (Y/M) | No. of Samples | Radiotherapy fractionb (Gy) and day count | Chemotherapyc | Antibiotics | |
|---|---|---|---|---|---|---|---|
| C1 | Male | 3.6 | 1 | None | None | None | |
| C2 | Male | 4.5 | 1 | None | None | None | |
| P1 | Male | 7 | 2 | 0 | Day 0 (B) | VAC | None |
| 21.6 | Day 12 (M) | VC | Sulfamethoxazole and trimethoprim | ||||
| P2 | Male | 7 | 3 | 0 | Day 0 (B) | VAC | None |
| 25.2 | Day 14 (M) | VC | None | ||||
| 46.8 | Day 26 (L) | VC | Sulfamethoxazole and trimethoprim | ||||
| P3 | Male | 4 | 3 | 0 | Day 0(B) | VAC | None |
| 28.8 | Day 16 (M) | VC | Levofloxacin | ||||
| 48.6 | Day 27 (L) | VC | Ceftriaxone, sulfamethoxazole and trimethoprim | ||||
Notes.
a
C, Control; P, Patient
b
B, Before; M, Mid; L, Last
c
V, Vincristine; A, Dactinomycin; C, Cyclophosphamide